GenSpera, Inc. (OTC: GNSZ) is a biotechnology company focused on the development and commercialization of promising, new therapeutics. GenSpera combines powerful insights and rigorous scientific methods to create new treatment options for patients. The company’s trailblazing therapeutics tackle challenging areas in oncology, and this work is motivated by a commitment to innovation, helping patients, and supported by an experienced and motivated team with deep pharmaceutical industry and scientific experience. For more information, visit the company’s website at www.genspera.com.